MAS
DGX icon

Meeder Advisory Services’s Quest Diagnostics DGX Stock Holding History

Meeder Advisory Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648K Sell
3,306
-199
-6% -$38.7K 0.03% 343
2025
Q4 		$608K Buy
3,505
+82
+2% +$14.9K 0.03% 357
2025
Q3 		$652K Sell
3,423
-86
-2% -$15.3K 0.03% 343
2025
Q2 		$630K Buy
3,509
+506
+17% +$87.9K 0.03% 333
2025
Q1 		$508K Buy
3,003
+465
+18% +$76.4K 0.03% 351
2024
Q4 		$383K Buy
2,538
+545
+27% +$84.8K 0.02% 402
2024
Q3 		$309K Buy
1,993
+198
+11% +$29.6K 0.02% 425
2024
Q2 		$246K Buy
1,795
+84
+5% +$11.5K 0.02% 450
2024
Q1 		$228K Sell
1,711
-74
-4% -$9.6K 0.02% 405
2023
Q4 		$246K Buy
1,785
+23
+1% +$3.02K 0.03% 375
2023
Q3 		$215K Sell
1,762
-330
-16% -$44K 0.03% 378
2023
Q2 		$294K Buy
2,092
+21
+1% +$2.9K 0.03% 363
2023
Q1 		$293K Buy
2,071
+349
+20% +$49.9K 0.03% 365
2022
Q4 		$269K Buy
+1,722
New +$247K 0.03% 352

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Meeder Advisory Services's DGX Position: Q1 2026 in Review

Meeder Advisory Services reduced its Quest Diagnostics (DGX) stake by 5.7% in Q1 2026, selling an estimated $38.7K and leaving 3,306 shares worth $648K. The position accounts for 0.03% of the portfolio, ranked #343.

Meeder Advisory Services first reported a position in DGX in Q4 2022 and has held it in 14 quarters since. The position peaked at $652K in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Meeder Advisory Services held 3,306 shares of Quest Diagnostics worth $648K as of Q1 2026.
  • Meeder Advisory Services sold 199 Quest Diagnostics shares in Q1 2026, an estimated $38.7K.
  • Quest Diagnostics made up 0.03% of Meeder Advisory Services's portfolio in Q1 2026, its #343 holding.
  • Meeder Advisory Services first reported a position in Quest Diagnostics in Q4 2022 and has held it in 14 quarters since.
  • Meeder Advisory Services's Quest Diagnostics position peaked at $652K in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.